FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/12/078687 [Registered on: 27/12/2024] Trial Registered Prospectively
Last Modified On: 14/12/2024
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Exploring the Efficacy of Ahiphenadi Vati and Sameergaja Kesari Rasa in the Management of Opioid Use Disorder 
Scientific Title of Study   A Randomized Comparative Trial to Evaluate the Efficacy of Ahiphenadi Vati and Sameergaja Kesari Rasa in Opioid Use Disorder 
Trial Acronym  NA 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DrRinkesh Vishnoi 
Designation  Ph.D. Scholar  
Affiliation  National institute of Ayurveda 
Address  Department of Agad Tantra, National institute of Ayurveda,Jorawar singh gate, Amer road, Jaipur

Jaipur
RAJASTHAN
302002
India 
Phone  8769213229  
Fax    
Email  rinkeshbishnoi29@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Prof. Anita Sharma 
Designation  Professor and HOD 
Affiliation  National institute of Ayurveda 
Address  Department of Agad Tantra, National institute of Ayurveda,Jorawar singh gate, Amer road, Jaipur

Jaipur
RAJASTHAN
302002
India 
Phone  9414078653  
Fax    
Email  anita31sharma@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  DrRinkesh Vishnoi 
Designation  Ph.D. Scholar  
Affiliation  National institute of Ayurveda 
Address  Department of Agad Tantra, National institute of Ayurveda,Jorawar singh gate, Amer road, Jaipur

Jaipur
RAJASTHAN
302002
India 
Phone  8769213229  
Fax    
Email  rinkeshbishnoi29@gmail.com  
 
Source of Monetary or Material Support  
National institute of Ayurveda jaipur, Rajasthan India 302002 
 
Primary Sponsor  
Name  National institute of ayurveda 
Address  National institute of Ayurveda (Deemed to be university), Jorawer singh gate, Amer road Jaipur, Rajasthan, India 302002 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 2  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sanjeev Sharma VC of National institute of Ayurveda  National institute of Ayurveda  Room no. 25, Depatment of Agad Tantra, National institute of ayurveda ,Jaipur 302002
Jaipur
RAJASTHAN 
919412635816

nia-rj@nic.in 
DrRinkesh vishnoi  National institute of Ayurveda  National institute of Ayurveda, Jorawar singh gate, amer road jaipur
Jaipur
RAJASTHAN 
8769213229

rinkeshbishnoi29@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee National Institute Of Ayurveda  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:F112||Opioid dependence. Ayurveda Condition: MADATYAYA-ARISHTAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Ahiphenadi vati, Reference: Rasatantrasara siddhprayog sangrha, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 125(mg), Frequency: tds, Bhaishajya Kal: Adhobhakta, Duration: 28 Days, anupAna/sahapAna: Yes(details: -Ushna jala), Additional Information: -tepering dase
2Comparator ArmDrugClassical(1) Medicine Name: Sameergaja kesari Rasa, Reference: Rasatantra sara evm siddhprayoga sangra, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 125(mg), Frequency: tds, Bhaishajya Kal: Adhobhakta, Duration: 28 Days, anupAna/sahapAna: Yes(details: -Ushna jala), Additional Information: -tapering dose
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients with early, mild and moderate symptoms with scores of 5-24 after evaluation in COWS scale.
Patients with early, mild and moderate symptoms with scores of 7-21 after evaluation in ISI scale.
Patients of either sex

 
 
ExclusionCriteria 
Details  Patients with severe score above 24 in COWS scale.
Patients with severe score above 21 in ISI scale
Patients with any other type of psychiatric disorder, any type of Venereal diseases, any major systemic diseases like carcinoma, heart diseases, hepatic and renal failure, DM, hypertension etc.
Patients who are receiving any contemporary de addiction treatment.
patients who has with any other substance addiction
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Changes in scores of COWS (Clinical opiate withdrawal scale).  4 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
Changes in score of Insomnia severity index  4 weeks 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   01/01/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="10" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary    my ph.d. study title is A Randomized Comparative Trial to Evaluate the Efficacy of Ahiphenadi  Vati and Sameergaja Kesari Rasa in Opioid Use Disorder, i in role patients after physical examination, and divided into 2 groups, one group will be given ahiphenadi vati and other groups will be given sameergaja kesari rasa 
Close